Our Portfolio
cancer biochip system
cancer biochip system
cancer biochip system
Translating cancer genomic data into personalized, targeted, and effective therapy and vaccine development.
The Cancer Biochip System (CBCS) is a device for in vitro targeting of abnormally expressed cancer genes in patient cells growing in a 3D matrix, for prediction of efficacious therapy.
By testing cancer cells growing in 3D, agents found with CBCS have higher likelihood of succeeding in clinical trials.
U.S. Patents # 7,537,913 B2, U.S. 8,110,375 B2, US 9,102,984 B2, US App. 13/292,221, Canadian Patent # 2,593,494, EPO 12 782 865.5
palpaid
cancer biochip system
cancer biochip system
To provide women, and primary care providers with inexpensive, easy-to-use tool to triage, visualize, and track changes in palpable breast lesions.
PalPaid is a handheld device that uses a tonometric lens to detect, image, and measure breast lesions.
It is not a substitute for mammography, but rather a complementary tool to monitor suspicious findings.
US Patent # 10687710
poc covid test
cancer biochip system
poc covid test
Making molecular diagnostics available to anybody and everywhere.
At-Home COVID Nucleic Acid Detection Kit for Rapid Molecular Diagnostics,
US Patent Application # 18/190,927, submitted 3/25/2022.